adenosine monophosphate has been researched along with Hendra Virus Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bunyan, E; Cihlar, T; de Wit, E; Feldmann, F; Feldmann, H; Goldin, K; Lo, MK; Lovaglio, J; Okumura, A; Porter, DP; Saturday, G; Spiropoulou, CF; Williamson, BN | 1 |
| Bannister, R; Cihlar, T; Cronin, J; de Wit, E; Feldmann, F; Feldmann, H; Gary, JM; Jordan, R; Klena, JD; Lo, MK; Nichol, ST; Patel, NR; Spiropoulou, CF; Zaki, SR | 1 |
2 other study(ies) available for adenosine monophosphate and Hendra Virus Infections
| Article | Year |
|---|---|
Late remdesivir treatment initiation partially protects African green monkeys from lethal Nipah virus infection.
Topics: Adenosine Monophosphate; Alanine; Animals; Brain; Chlorocebus aethiops; Henipavirus Infections; Nipah Virus | 2023 |
Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge.
Topics: Adenosine Monophosphate; Alanine; Animals; Brain; Chlorocebus aethiops; Female; Henipavirus Infections; Male; Meningoencephalitis; Neutralization Tests; Nipah Virus; Viremia; Virus Replication | 2019 |